# Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy

> **NCT00188383** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 132 (—)

## Conditions studied

- Hyperalgesia
- Pain
- Prostate Cancer

## Interventions

- **DRUG:** Amantadine

## Key facts

- **NCT ID:** NCT00188383
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 132 (—)
- **Last updated:** 2006-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188383, "Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00188383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*